These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34307440)

  • 21. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal microbiota and bile acid interactions with systemic and adipose tissue metabolism in diet-induced weight loss of obese postmenopausal women.
    Alemán JO; Bokulich NA; Swann JR; Walker JM; De Rosa JC; Battaglia T; Costabile A; Pechlivanis A; Liang Y; Breslow JL; Blaser MJ; Holt PR
    J Transl Med; 2018 Sep; 16(1):244. PubMed ID: 30176893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic Effects of Replacing Sugar-Sweetened Beverages with Artificially-Sweetened Beverages in Overweight Subjects with or without Hepatic Steatosis: A Randomized Control Clinical Trial.
    Campos V; Despland C; Brandejsky V; Kreis R; Schneiter P; Boesch C; Tappy L
    Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
    Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
    mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resolvin D1 ameliorates hepatic steatosis by remodeling the gut microbiota and restoring the intestinal barrier integrity in DSS-induced chronic colitis.
    Zeng C; Liu X; Zhu S; Xiong D; Zhu L; Hou X; Zou K; Bai T
    Int Immunopharmacol; 2022 Feb; 103():108500. PubMed ID: 34974401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucagon and Liver Fat are Downregulated in Response to Very Low-calorie Diet in Patients with Obesity and Type-2 Diabetes.
    Haas SL; Löfgren P; Stål P; Hoffstedt J
    Exp Clin Endocrinol Diabetes; 2022 Jan; 130(1):55-60. PubMed ID: 32767285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inulin Improves Diet-Induced Hepatic Steatosis and Increases Intestinal
    Pérez-Monter C; Álvarez-Arce A; Nuño-Lambarri N; Escalona-Nández I; Juárez-Hernández E; Chávez-Tapia NC; Uribe M; Barbero-Becerra VJ
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.
    Harrison SA; Fecht W; Brunt EM; Neuschwander-Tetri BA
    Hepatology; 2009 Jan; 49(1):80-6. PubMed ID: 19053049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationships between reduction in body weight and reduction in blood pressure and improvement of glucose and lipid metabolism induced by short-term calorie restriction in overweight hypertensive women.
    Adachi T; Kawamura M; Hiramori K
    Hypertens Res; 1996 Jun; 19 Suppl 1():S57-60. PubMed ID: 9240766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A legume-based hypocaloric diet reduces proinflammatory status and improves metabolic features in overweight/obese subjects.
    Hermsdorff HH; Zulet MÁ; Abete I; Martínez JA
    Eur J Nutr; 2011 Feb; 50(1):61-9. PubMed ID: 20499072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial.
    Kraus WE; Bhapkar M; Huffman KM; Pieper CF; Krupa Das S; Redman LM; Villareal DT; Rochon J; Roberts SB; Ravussin E; Holloszy JO; Fontana L;
    Lancet Diabetes Endocrinol; 2019 Sep; 7(9):673-683. PubMed ID: 31303390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calorie shifting diet versus calorie restriction diet: a comparative clinical trial study.
    Davoodi SH; Ajami M; Ayatollahi SA; Dowlatshahi K; Javedan G; Pazoki-Toroudi HR
    Int J Prev Med; 2014 Apr; 5(4):447-56. PubMed ID: 24829732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial.
    Heilbronn LK; de Jonge L; Frisard MI; DeLany JP; Larson-Meyer DE; Rood J; Nguyen T; Martin CK; Volaufova J; Most MM; Greenway FL; Smith SR; Deutsch WA; Williamson DA; Ravussin E;
    JAMA; 2006 Apr; 295(13):1539-48. PubMed ID: 16595757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut Microbiota Serves a Predictable Outcome of Short-Term Low-Carbohydrate Diet (LCD) Intervention for Patients with Obesity.
    Zhang S; Wu P; Tian Y; Liu B; Huang L; Liu Z; Lin N; Xu N; Ruan Y; Zhang Z; Wang M; Cui Z; Zhou H; Xie L; Chen H; Sun J
    Microbiol Spectr; 2021 Oct; 9(2):e0022321. PubMed ID: 34523948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of gut microbiota and fatty acid metabolism on dyslipidemia following weight-loss diets in women: Results from a randomized controlled trial.
    Ma Y; Sun Y; Sun L; Liu X; Zeng R; Lin X; Li Y
    Clin Nutr; 2021 Nov; 40(11):5511-5520. PubMed ID: 34656033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haptoglobin phenotype influences the effectiveness of diet-induced weight loss in middle-age abdominally obese women with metabolic abnormalities.
    Tang KY; Huang SY; Cheng TM; Bai CH; Chang JS
    Clin Nutr; 2020 Jan; 39(1):225-233. PubMed ID: 30737047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients Undergoing Low Calorie Diet.
    Shidfar F; Bahrololumi SS; Doaei S; Mohammadzadeh A; Gholamalizadeh M; Mohammadimanesh A
    Can J Gastroenterol Hepatol; 2018; 2018():1053710. PubMed ID: 29850450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diet Consisting of Balanced Yogurt, Fruit, and Vegetables Modifies the Gut Microbiota and Protects Mice against Nonalcoholic Fatty Liver Disease.
    Kong CY; Li ZM; Han B; Zhang ZY; Chen HL; Zhang SL; Xu JQ; Mao YQ; Zhao YP; Wang LS
    Mol Nutr Food Res; 2019 Oct; 63(19):e1900249. PubMed ID: 31271251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TMAVA, a Metabolite of Intestinal Microbes, Is Increased in Plasma From Patients With Liver Steatosis, Inhibits γ-Butyrobetaine Hydroxylase, and Exacerbates Fatty Liver in Mice.
    Zhao M; Zhao L; Xiong X; He Y; Huang W; Liu Z; Ji L; Pan B; Guo X; Wang L; Cheng S; Xu M; Yang H; Yin Y; Garcia-Barrio MT; Chen YE; Meng X; Zheng L
    Gastroenterology; 2020 Jun; 158(8):2266-2281.e27. PubMed ID: 32105727
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.